Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18925934rdf:typepubmed:Citationlld:pubmed
pubmed-article:18925934lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0596901lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0205107lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0439751lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0913822lld:lifeskim
pubmed-article:18925934lifeskim:mentionsumls-concept:C0913823lld:lifeskim
pubmed-article:18925934pubmed:dateCreated2008-11-21lld:pubmed
pubmed-article:18925934pubmed:abstractTextThe membrane proximal region (MPR) of the transmembrane subunit, gp41, of the HIV envelope glycoprotein plays a critical role in HIV-1 infection of CD4+ target cells and CD4-independent mucosal entry. It contains continuous epitopes recognized by neutralizing IgG antibodies 2F5, 4E10 and Z13, and is therefore considered to be a promising target for vaccine design. Moreover, some MPR-derived peptides, such as T20 (enfuvirtide), are in clinical use as HIV-1 inhibitors. We have shown that an extended MPR peptide, P5, harbouring the lectin-like domain of gp41 and a calcium-binding site, is implicated in the interaction of HIV with its mucosal receptor. We now investigate the potential antiviral activities of P5 and other such long MPR-derived peptides. Structural studies of gp41 MPR-derived peptides using circular dichroism showed that the peptides P5 (a.a.628-683), P1 (a.a.648-683), P5L (a.a.613-683) and P7 (a.a.613-746) displayed a well-defined alpha-helical structure. Peptides P5 inhibited HIV-1 envelope mediated cell-cell fusion and infection of peripheral blood mononuclear cells by both X4- and R5-tropic HIV-1 strains, whereas peptides P5 mutated in the calcium binding site or P1 lacked antiviral activity, when P5L blocked cell fusion in contrast to P7. Strikingly, P5 inhibited CD4-dependent infection by T20-resistant R5-tropic HIV-1 variants. Cell-cell fusion studies indicated that the anti-HIV-1 activity of P5, unlike T20, could not be abrogated in the presence of the N-terminal leucine zipper domain (LZ). These results suggested that P5 could serve as a potent fusion inhibitor.lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:languageenglld:pubmed
pubmed-article:18925934pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:citationSubsetIMlld:pubmed
pubmed-article:18925934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18925934pubmed:statusMEDLINElld:pubmed
pubmed-article:18925934pubmed:issn1742-4690lld:pubmed
pubmed-article:18925934pubmed:authorpubmed-author:ClavelFrançoi...lld:pubmed
pubmed-article:18925934pubmed:authorpubmed-author:BomselMorgane...lld:pubmed
pubmed-article:18925934pubmed:authorpubmed-author:AlfsenAnnette...lld:pubmed
pubmed-article:18925934pubmed:authorpubmed-author:TudorDanielaDlld:pubmed
pubmed-article:18925934pubmed:authorpubmed-author:YuHuifengHlld:pubmed
pubmed-article:18925934pubmed:authorpubmed-author:LabrosseBeatr...lld:pubmed
pubmed-article:18925934pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18925934pubmed:volume5lld:pubmed
pubmed-article:18925934pubmed:ownerNLMlld:pubmed
pubmed-article:18925934pubmed:authorsCompleteYlld:pubmed
pubmed-article:18925934pubmed:pagination93lld:pubmed
pubmed-article:18925934pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:meshHeadingpubmed-meshheading:18925934...lld:pubmed
pubmed-article:18925934pubmed:year2008lld:pubmed
pubmed-article:18925934pubmed:articleTitlePeptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection.lld:pubmed
pubmed-article:18925934pubmed:affiliationDepartement de Biologie Cellulaire, (Cell Biology Department), Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), 22 rue Mechain, 75014 Paris, France. yu@cochin.inserm.frlld:pubmed
pubmed-article:18925934pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18925934pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18925934lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18925934lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18925934lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18925934lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18925934lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18925934lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18925934lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18925934lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18925934lld:pubmed
More...